Predictors of Subsequent Heart Failure After Left Atrial Appendage Closure

Dae-Young Kim1, Min Ji Kim1, Jiwon Seo1

  • 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine.

Insights

Left atrial appendage occlusion (LAAO) can increase heart failure (HF) risk. Prior HF history, higher E/e

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Left atrial appendage occlusion (LAAO) is crucial for stroke prevention in atrial fibrillation patients.
  • LAAO may negatively impact left atrial compliance and reservoir function, potentially increasing heart failure (HF) risk.

Purpose of the Study:

  • To identify predictors of subsequent heart failure (HF) following successful left atrial appendage occlusion (LAAO).

Main Methods:

  • Analysis of 98 patients who underwent LAAO, with a primary endpoint of unexpected HF admission.
  • Multivariate analysis to identify independent predictors of HF admission.
  • Comparison of HF incidence in LAAO patients versus a propensity score-matched control group.

Main Results:

  • 16% of patients experienced hospital HF admission during a mean follow-up of 36 months.
  • Higher E/e', increased left ventricular mass index, prior HF history, and lower left atrial strain were independently associated with HF admission.
  • LAAO patients showed a significantly higher incidence of subsequent HF compared to controls.

Conclusions:

  • Left atrial appendage occlusion is associated with an increased occurrence of heart failure.
  • Key predictors for developing HF post-LAAO include prior HF history, left ventricular mass index, E/e' ratio, and abnormal left atrial strain.
  • These identified parameters should be evaluated prior to performing LAAO.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
51
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
124
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
61